Pregabalin and Emla drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pregabalin (pregabalin) and Emla (lidocaine; prilocaine). Common drug interactions include weight increased among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Pregabalin and Emla. It is created by eHealthMe based on reports of 87 people who take the same drugs from the FDA, and is updated regularly.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,071 Pregabalin users. Check the latest studies of Pregabalin.

What is Emla?

Emla has active ingredients of lidocaine; prilocaine. eHealthMe is studying from 5,276 Emla users. Check the latest studies of Emla.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

87 people who take Pregabalin and Emla together, and have interactions are studied.

Pregabalin and Emla drug interactions.

What are the common drug interactions of Pregabalin and Emla, by gender? *:

female:

  1. Weight increased
  2. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  3. Thrombocytopenic purpura (a bleeding disorder in which the immune system destroys platelets)
  4. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  5. Suicidal ideation
  6. Hallucination, visual (seeing things that aren't there)
  7. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
  8. Drug ineffective
  9. Fatigue (feeling of tiredness)
  10. Pyrexia (fever)

male:

  1. Fatigue (feeling of tiredness)
  2. Headache (pain in head)
  3. Influenza like illness
  4. Infusion related reaction
  5. Leukaemia (blood or bone marrow cancer)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Myalgia (muscle pain)
  8. Oedema peripheral (superficial swelling)
  9. Pneumonia
  10. Pyrexia (fever)

What are the common drug interactions of Pregabalin and Emla, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Weight increased
  2. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  3. Thrombocytopenic purpura (a bleeding disorder in which the immune system destroys platelets)
  4. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  5. Suicidal ideation

20-29:

n/a

30-39:

  1. Chills (felling of cold)
  2. Fatigue (feeling of tiredness)
  3. Arterial injury
  4. Arthralgia (joint pain)
  5. Breast mass
  6. Bronchial wall thickening
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Infection
  9. Influenza
  10. Lymphadenopathy (disease or enlargement of lymph nodes)

40-49:

  1. Pericardial effusion (fluid around the heart)

50-59:

  1. Abdominal pain
  2. Alanine aminotransferase increased
  3. Aspartate aminotransferase increased
  4. Blood alkaline phosphatase increased
  5. Cough
  6. Dyspnoea (difficult or laboured respiration)
  7. Hypersensitivity
  8. Leukopenia (less number of white blood cells in blood)
  9. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  10. Muscular weakness (muscle weakness)

60+:

  1. Hallucination, visual (seeing things that aren't there)
  2. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
  3. Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
  4. Arrhythmia (irregular heartbeat)
  5. Clostridium test positive
  6. Dermatosis (a disease of the skin, esp. one that does not cause inflammation)
  7. Diarrhoea
  8. Drug abuse
  9. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  10. Full blood count decreased

What are the existing conditions these people have? *

  1. Complex Regional Pain Syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet)): 48 people, 55.17%
  2. Pain: 14 people, 16.09%
  3. Constipation: 7 people, 8.05%
  4. Stress And Anxiety: 6 people, 6.90%
  5. Depression: 6 people, 6.90%
  6. Headache (pain in head): 5 people, 5.75%

* Approximation only. Some reports may have incomplete information.

Do you take Pregabalin and Emla?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pregabalin and Emla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Emla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pregabalin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Emla and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on pregabalin and lidocaine; prilocaine (the active ingredients of Pregabalin and Emla, respectively), and Pregabalin and Emla (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: